Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias P Müller

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cell Chemical Biology|January 21, 2018
Try Me: Promiscuous Inhibitors Still Allow for Selective Targeted Protein DegradationMatthias P Müller, Daniel Rauh
Biological Chemistry|April 24, 2026
Fred Wittinghofer and the GTP/GDP-binding proteinsRoger S Goody, Matthias P Müller
Small Gtpases|January 6, 2017
Molecular control of Rab activity by GEFs, GAPs and GDIMatthias P Müller, Roger S Goody
ACS Chemical Biology|December 13, 2019
Augmented Reality in Scientific Publications - Taking the Visualization of 3D Structures to the Next LevelPatrik Wolle, Matthias P Müller, Daniel Rauh
ACS Chemical Biology|March 17, 2018
Augmented Reality in Scientific Publications-Taking the Visualization of 3D Structures to the Next LevelPatrik Wolle, Matthias P Müller, Daniel Rauh
Journal of Medicinal Chemistry|April 15, 2024
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer TherapyTonia Kirschner, Matthias P Müller, Daniel Rauh
Cell Chemical Biology|August 6, 2019
Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small MoleculesRoger S Goody, Matthias P Müller, Daniel Rauh
Small Gtpases|January 28, 2017
Multivalency in Rab effector interactionsAmrita Rai, Roger S Goody, Matthias P Müller
Traffic (Copenhagen, Denmark)|August 21, 2012
Bacterial pathogens commandeer Rab GTPases to establish intracellular nichesMary-Pat Stein, Matthias P Müller, Angela Wandinger-Ness
RSC Medicinal Chemistry|January 22, 2021
KRasG12C inhibitors in clinical trials: a short historical perspectiveLisa Goebel, Matthias P Müller, Roger S Goody, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cell Chemical Biology|January 21, 2018
Try Me: Promiscuous Inhibitors Still Allow for Selective Targeted Protein DegradationMatthias P Müller, Daniel Rauh
Biological Chemistry|April 24, 2026
Fred Wittinghofer and the GTP/GDP-binding proteinsRoger S Goody, Matthias P Müller
Small Gtpases|January 6, 2017
Molecular control of Rab activity by GEFs, GAPs and GDIMatthias P Müller, Roger S Goody
ACS Chemical Biology|December 13, 2019
Augmented Reality in Scientific Publications - Taking the Visualization of 3D Structures to the Next LevelPatrik Wolle, Matthias P Müller, Daniel Rauh
ACS Chemical Biology|March 17, 2018
Augmented Reality in Scientific Publications-Taking the Visualization of 3D Structures to the Next LevelPatrik Wolle, Matthias P Müller, Daniel Rauh
Journal of Medicinal Chemistry|April 15, 2024
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer TherapyTonia Kirschner, Matthias P Müller, Daniel Rauh
Cell Chemical Biology|August 6, 2019
Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small MoleculesRoger S Goody, Matthias P Müller, Daniel Rauh
Small Gtpases|January 28, 2017
Multivalency in Rab effector interactionsAmrita Rai, Roger S Goody, Matthias P Müller
Traffic (Copenhagen, Denmark)|August 21, 2012
Bacterial pathogens commandeer Rab GTPases to establish intracellular nichesMary-Pat Stein, Matthias P Müller, Angela Wandinger-Ness
RSC Medicinal Chemistry|January 22, 2021
KRasG12C inhibitors in clinical trials: a short historical perspectiveLisa Goebel, Matthias P Müller, Roger S Goody, et al.
Pageof 5